Notable insider buying and selling activity across public companies.
Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.
13,122 total articles
Paul Francis McNeice, serving as the Chief Accounting Officer at American Well Corp (NYSE: AMWL), executed a mandatory sale of 653 shares of Class A Common Stock on July 1, 2026. The transaction, valued at $6,092, was triggered by tax obligations associated with the vesting of restricted stock units rather than discretionary trading. This activity …
CoreCivic, Inc. (NYSE:CXW) Chief Administrative Officer Cole G. Carter executed a transaction involving the sale of 12,500 shares on July 1, 2026. This move follows a period of significant stock appreciation and coincides with the company's recent financial reporting and governance milestones. The transaction highlights executive activity within th…
Tim Truels Hansen, Chief Commercial Officer of Dorian LPG Ltd. (NASDAQ:LPG), executed a sale of 20,000 common shares on June 30, 2026, totaling $707,526 at $35.3763 per share. This transaction reduces his direct holdings to 157,842 shares, including 32,317 unvested restricted stock units. The sale follows a period of stock volatility, with LPG down…
Hayward Holdings, Inc. (NASDAQ: HAYW) President and CEO Kevin Holleran executed a series of stock sales totaling approximately $2.9 million over two consecutive days in late June and early July 2026, according to filings with the Securities and Exchange Commission. These transactions, conducted under pre-established Rule 10b5-1 trading plans, invol…
D. James Bidzos, serving as Executive Chairman, President, and CEO of VeriSign Inc., executed a series of sales totaling $828,110 in company common stock on June 30, 2026. The transaction involved the disposition of 3,300 shares, sold at weighted average prices between $248.98 and $252.50. Following these sales, Bidzos retains a direct stake of 426…
Mark Hirschhorn, Chief Financial Officer of American Well Corp (NASDAQ:AMWL), executed a mandatory sale of 4,299 shares on July 1, 2026, to satisfy tax obligations from restricted stock unit vesting. The automatic transaction occurred as AMWL stock neared its 52-week high of $9.96, following an 86% gain over the prior six months. Post-transaction, …
Gary E. Dickerson, the President and Chief Executive Officer of Applied Materials Inc., has executed a substantial divestment of company equity, selling a total of 78,321 shares of common stock over a two-day period in late June 2026. The transactions, which spanned June 29 and June 30, totaled approximately $55.5 million in value. The sales occurr…
American Well Corp (NASDAQ: AMWL) is navigating a period of executive transition and financial recalibration. Chief Product & Technology Officer Dmitry Zamansky recently sold a portion of his holdings to satisfy tax obligations from restricted stock unit settlements. Concurrently, co-founder Dr. Roy Schoenberg has exited the board to assume a leade…
Kyle Clark, President and CEO of BETA Technologies, Inc. (NASDAQ:BETA), recently executed a series of stock sales totaling approximately $494,691. The transactions were facilitated through The Godric’s Hollow Trust under a pre-established 10b5-1 trading plan. This activity occurs as BETA Technologies navigates a challenging market environment, with…
Chad Michael Frazell, serving as the Chief HR Officer at Casey's General Stores Inc. (NASDAQ:CASY), executed a significant divestment of company equity on June 30, 2026. The transaction involved the sale of 3,013 shares, generating total proceeds of $2,372,710. This executive move takes place against a backdrop of strong recent performance for the …
Phyllis Gotlib, President of International at American Well Corp (NASDAQ: AMWL), executed a mandatory share sale on July 1, 2026, to cover tax obligations from vesting restricted stock units. The transaction involved 6,677 shares at $9.33 per share, totaling approximately $62,296. This automatic sell-to-cover mechanism is standard for satisfying ta…
David A. Duffield, a significant ten percent owner of Workday, Inc. (NASDAQ:WDAY), executed a substantial divestment of 107,500 Class A Common Stock shares on June 30, 2026, totaling approximately $13,119,166. The transactions were carried out through a Rule 10b5-1 trading plan established by the David A. Duffield Trust in late 2025. The sale price…
Charles River Laboratories International, Inc. (NASDAQ: CRL) director James C. Foster has executed a substantial sale of company shares, reducing his direct stake by approximately $16.8 million. The transaction, reported on June 29, 2026, was carried out under a pre-arranged Rule 10b5-1 trading plan established earlier in the year. This insider act…
Control Empresarial de Capitales S.A. de C.V., a key shareholder in PBF Energy Inc. (PBF), executed a series of sales totaling 850,000 Class A Common Shares for approximately $39.5 million across June 29 and 30, 2026. The transactions occurred at weighted average prices between $46.0062 and $47.006 per share, coinciding with a period where PBF shar…
Kent A. Hansen, Chief Financial Officer and Executive Vice President of Kingsway Corp (NASDAQ: KWY), acquired 149 shares of the company's common stock on June 30, 2026, totaling $1,557. The transaction was executed through the Kingsway America Inc. Employee Share Purchase Plan (ESPP), which allows eligible employees to contribute up to 5% of their …
Shane Barton, the principal accounting officer at BioAge Labs, Inc. (NASDAQ:BIOA), executed a series of stock sales totaling approximately $1.58 million across June 29 and June 30, 2026. The transactions occurred while the company's shares traded near a 52-week high, even as the firm advances its lead cardiovascular candidate, BGE-102, into Phase 2…
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Chief Financial Officer David Kirske executed a transaction involving the sale of 8,543 shares of the company's common stock on June 30, 2026. The divestment, valued at $36,428, was facilitated to satisfy personal income tax liabilities stemming from the settlement of a restricted stock unit award. Kirske's sa…
John Roderick ten Bosch, Senior Vice President of Laboratory Operations at BillionToOne, Inc. (NASDAQ:BLLN), executed a sale of 1,416 shares of Class A Common Stock on June 29, 2026, totaling $169,920. The transaction was conducted under a Rule 10b5-1 plan established on March 6, 2026. Following the sale, ten Bosch retains direct ownership of 33,55…
Candel Therapeutics, Inc. (NASDAQ: CADL) reported that Chief Scientific Officer Francesca Barone sold 23,447 shares of the company's common stock on June 29, 2026. The transaction, valued at approximately $235,768, was executed at a weighted average price of $10.0554 per share, with individual prices ranging between $10.00 and $10.14. This sale was…
Mark T. Bertolini, the Chief Executive Officer of Oscar Health, Inc. (NASDAQ: OSCR), concluded a series of stock transactions totaling $35,767,321 on June 29 and June 30, 2026. The divestiture of 1,238,996 Class A Common Stock shares was executed to satisfy tax withholding requirements linked to the vesting of performance stock units. This executiv…
Atul Dandekar, Chief Scientific and Business Officer at Maze Therapeutics, Inc., executed a series of stock transactions on June 29, 2026, involving both the sale and acquisition of company shares. The transactions were conducted under a pre-arranged trading plan established in late 2025. Dandekar sold 7,500 shares for $210,150 while simultaneously…
CNO Financial Group, Inc. (NASDAQ:CNO) CEO Gary C. Bhojwani executed a significant divestment of company equity on June 30, 2026, liquidating approximately $4.43 million in common stock. The transaction followed the exercise of employee stock options and occurred as shares approached their 52-week high, raising questions regarding executive timing …
Dennis Polk, Chair of Hyve Solutions at TD SYNNEX CORP (NASDAQ:SNX), executed a series of stock transactions on June 30, 2026. The transactions included the sale of 10,000 shares of TD SYNNEX common stock, totaling approximately $2.68 million. Additionally, Polk acquired 10,000 shares through the exercise of stock options valued at about $1.07 mill…
George K. Ng, Chief Executive Officer and Director at Processa Pharmaceuticals, Inc., purchased 3,057 shares of common stock on July 1, 2026, at $1.93 per share. The transaction brings his direct holdings to 15,492 shares, while he also holds 3,488 shares through the George Ng IRRA FOB George Ng entity and 800 shares via the Ng Cha Family Trust. Th…
Rocco F. Tarasi III, the Chief Marketing Officer at CNO Financial Group, Inc. (NASDAQ:CNO), executed a sale of 1,891 shares of the company's common stock on July 1, 2026. This transaction, valued at approximately $97,027, was conducted at a price of $51.31 per share. Following the sale, Tarasi's direct ownership stands at 77,300 shares. The divestm…
